pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

AUROBINDO PHARMA

USupdated 2mo ago
community read0 votes
pipeline
12
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(12)

pipeline depth12 products
Unknown: 12
12Unknown
drug
AMLODIPINE AND VALSARTAN
drug
CHATEAL EQ
drug
DABIGATRAN ETEXILATE
drug
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
drug
GALANTAMINE
drug
GLYBURIDE AND METFORMIN HYDROCHLORIDE
drug
IBUPROFEN AND PSEUDOEPHEDRINE HCL
drug
MOMETASONE FUROATE MONOHYDRATE
drug
MUCUS RELIEF DM MAXIMUM STRENGTH
drug
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE
drug
RIVASTIGMINE TARTRATE
drug
TRI-LO-MILI

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view AUROBINDO PHARMA jobs →

News

no news has mentioned this company yet
identifiers
country
US
source
openfda_drugsfda
mentioned in
0news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?